Home
Clinical Resources Search
PQI: Elranatamab (Elrexfio) for the Management of Relapsed/Refractory Multiple Myeloma

Elranatamab (Elrexfio) for the Management of Relapsed/Refractory Multiple Myeloma

Download PQI pdf

Last Updated: August 3, 2025

By: Amir Ali, PharmD, BCOP

About this PQI

The document outlines detailed clinical considerations, dosing schedules, and adverse effect management strategies for elranatamab administration, as well as patient-centered activities and guidelines for healthcare providers.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Elranatamab (Elrexfio) for the Management of Relapsed/Refractory Multiple Myeloma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma

PQI: HER2 Immunohistochemistry Testing in Metastatic Breast Cancer: Guiding Treatment Decisions and the Role of Sacituzumab Govitecan

PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia

PQI: Streamlining Enrollment in the Medicare Prescription Payment Plan (MPPP)

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

PQI in Action: Darolutamide (Nubeqa)

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

S10 E7: Scaling Hope: The Future of Cell Therapy Access

S10 E8: TheOncDoc on AI: What Actually Matters for Oncology Teams

S10 E6: Modern Antibody-drug conjugates and New CINV Challenges

S10 E5: Best Practices for Subcutaneous Administration of Anticancer Therapies

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bi-Specific

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

S7 Ep 8: Sickle Cell Disease Insights

Teclistamab and Talquetamab

Pomalidomide

Selinexor

Melphalan

PQI: Belantamab Mafodotin (Blenrep) for the Management of Multiple Myeloma

Teclistamab and Talquetamab

Daratumumab and CyBorD

Doxorubicin

Treatment Support Kit: Elranatamab

Elranatamab

Up Close with Elranatamab

Elranatamab

Up Close with Elranatamab

Elacestrant

PQI: Elacestrant (Orserdu)

PQI in Action: Capivasertib (Truqap) Patient Management

Loncastuximab Tesirine

Epcoritamab and GemOx

Glofitamab and GemOx